Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that hair loss treatments should be tailored to the specific type of alopecia and individual patient needs.

The skin has multiple layers and cells, serves as a protective barrier, helps regulate temperature, enables sensation, affects appearance, and is involved in vitamin D synthesis.

Suppressing eIF4E can prevent hair loss from chemotherapy.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.

Mice without the vitamin D receptor gene lose hair due to disrupted hair follicle cycles.

Etretinate treatment changed hair growth patterns in many patients.

Mini rats have thinner skin, more fat, and different hair cycles than Wistar rats due to lower growth hormone levels.

Hairless mice have longer hair follicles and abnormal structures during the catagen phase.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

Gambogic Amide may prevent hair greying and promote hair growth by maintaining hair pigmentation.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

Microneedle delivery of a special collagen shows promise for treating hair loss.

Personalized multimodal treatment significantly improved hair growth and scalp coverage in androgenetic alopecia without side effects.

DP cells interact with immune cells, possibly causing hair loss in Alopecia Areata.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

Exosomes may help stimulate hair growth and improve hair loss conditions like androgenic alopecia.

Anagen effluvium is a reversible condition causing sudden hair loss, often due to chemotherapy or head radiation.

Adenosine and caffeine can promote hair growth.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Nutritional supplements can significantly reduce hair loss in telogen effluvium after three months.

Hormones significantly affect hair growth and loss, with potential for new treatments.

Grape seed extract is good for skin care, with antioxidant, anti-inflammatory, and anti-cancer effects.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Truncated LTBP-1 disrupts TGF-beta signaling, affecting hair growth.

Knocking out the FGF5 gene in sheep increased wool production and hair-follicle density.

The medicine Cyclosporin A might cause excessive hair growth by reducing a protein that controls hair growth.

Hair follicle cells change their DNA packaging during growth cycles and when grown in the lab.

A woman's hair loss was due to trichotillomania, which is often misdiagnosed and can require different treatments based on age and underlying conditions.